title: [Efficacy and safety of generic imatinib mesylate capsules produced in China for newly diagnosed chronic myeloid leukemia in chronic phase patients].
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Juan
authors: J
authors: Chen
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Li
authors: L
authors: Zhou
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Shenghong
authors: S
authors: Du
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Hongying
authors: H
authors: Lu
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Shujun
authors: S
authors: Sun
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Junmin
authors: J
authors: Li
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Weili
authors: W
authors: Zhao
authors: Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
authors: Zhixiang
authors: Z
authors: Shen
mesh_terms: D002214:Capsules; D002681:China; D016568:Drugs, Generic; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase
chemical_list: D002214:Capsules; D016568:Drugs, Generic; D000068877:Imatinib Mesylate